Published in Cochrane Database Syst Rev on January 20, 2010
Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT) (ADEPTT) | NCT03302299
Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med (2011) 4.29
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis (2014) 3.69
New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med (2011) 3.46
Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med (2012) 3.44
Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med (2011) 3.29
Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial. Lancet (2014) 3.21
Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial. Lancet Infect Dis (2013) 2.95
Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme. AIDS (2010) 2.60
Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis. Sci Transl Med (2013) 2.28
Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence. Pulm Med (2013) 1.98
Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr (2011) 1.95
Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? Int J Tuberc Lung Dis (2011) 1.76
Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. Clin Infect Dis (2012) 1.57
How can mathematical models advance tuberculosis control in high HIV prevalence settings? Int J Tuberc Lung Dis (2014) 1.49
Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV. Int J Tuberc Lung Dis (2014) 1.46
Predictive value of interferon-gamma release assays for postpartum active tuberculosis in HIV-1-infected women. Int J Tuberc Lung Dis (2013) 1.41
The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study. AIDS (2010) 1.37
Latent tuberculosis: what the host "sees"? Immunol Res (2011) 1.35
Active tuberculosis case-finding among pregnant women presenting to antenatal clinics in Soweto, South Africa. J Acquir Immune Defic Syndr (2011) 1.24
TB diagnostic capacity in sub-Saharan African HIV care settings. J Acquir Immune Defic Syndr (2012) 1.22
HIV and tuberculosis--science and implementation to turn the tide and reduce deaths. J Int AIDS Soc (2012) 1.21
Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy. Expert Rev Anti Infect Ther (2011) 1.20
Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting? J Acquir Immune Defic Syndr (2011) 1.19
Symptom screening among HIV-infected pregnant women is acceptable and has high negative predictive value for active tuberculosis. Clin Infect Dis (2011) 1.14
Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithms. Eur Respir J (2011) 1.13
Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings. Proc Natl Acad Sci U S A (2014) 1.12
Recent developments in treatment of latent tuberculosis infection. Indian J Med Res (2011) 1.09
Research questions and priorities for tuberculosis: a survey of published systematic reviews and meta-analyses. PLoS One (2012) 1.09
Quantifying the burden and trends of isoniazid resistant tuberculosis, 1994-2009. PLoS One (2011) 1.08
Epidemiology of tuberculosis and HIV: recent advances in understanding and responses. Proc Am Thorac Soc (2011) 1.07
Close contact investigation of TB in high-burden, low- and middle-income countries. Malays Fam Physician (2014) 1.07
Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis. BMC Infect Dis (2014) 1.04
Prevalence of TB/HIV co-infection in countries except China: a systematic review and meta-analysis. PLoS One (2013) 1.01
The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study. BMC Infect Dis (2010) 0.98
Factors associated with adherence to treatment with isoniazid for the prevention of tuberculosis amongst people living with HIV/AIDS: a systematic review of qualitative data. PLoS One (2014) 0.98
Comparison of trends in tuberculosis incidence among adults living with HIV and adults without HIV--Kenya, 1998-2012. PLoS One (2014) 0.97
Current integration of tuberculosis (TB) and HIV services in South Africa, 2011. PLoS One (2013) 0.97
Factors associated with anti-tuberculosis medication adverse effects: a case-control study in Lima, Peru. PLoS One (2011) 0.97
Determinant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa, Ethiopia: a case control study. PLoS One (2013) 0.96
Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial. PLoS One (2012) 0.96
Recent developments in the diagnosis and management of tuberculosis. NPJ Prim Care Respir Med (2016) 0.95
PEPFAR support for the scaling up of collaborative TB/HIV activities. J Acquir Immune Defic Syndr (2012) 0.95
Modelling the performance of isoniazid preventive therapy for reducing tuberculosis in HIV endemic settings: the effects of network structure. J R Soc Interface (2011) 0.94
Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. Lancet (2015) 0.94
Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: a cohort study. BMJ Open (2012) 0.93
Performance of symptom-based tuberculosis screening among people living with HIV: not as great as hoped. AIDS (2014) 0.93
Improving tuberculosis screening and isoniazid preventive therapy in an HIV clinic in Addis Ababa, Ethiopia. Int J Tuberc Lung Dis (2013) 0.92
A 10-year population based study of 'opt-out' HIV testing of tuberculosis patients in Alberta, Canada: national implications. PLoS One (2014) 0.91
The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life. BMC Med (2014) 0.90
The 2015 Clinical Guidelines for the Treatment and Prevention of Opportunistic Infections in HIV-Infected Koreans: Guidelines for Opportunistic Infections. Infect Chemother (2016) 0.90
Perceived barriers to the implementation of Isoniazid preventive therapy for people living with HIV in resource constrained settings: a qualitative study. Pan Afr Med J (2014) 0.89
Interventions to improve delivery of isoniazid preventive therapy: an overview of systematic reviews. BMC Infect Dis (2014) 0.89
Point-of-care C-reactive protein testing to facilitate implementation of isoniazid preventive therapy for people living with HIV. J Acquir Immune Defic Syndr (2014) 0.88
Systematic review of TST responses in people living with HIV in under-resourced settings: implications for isoniazid preventive therapy. PLoS One (2012) 0.88
Latent tuberculosis infection in a Malaysian prison: implications for a comprehensive integrated control program in prisons. BMC Public Health (2014) 0.87
Improving the prevention, diagnosis and treatment of TB among people living with HIV: the role of operational research. J Int AIDS Soc (2011) 0.87
Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas. J Infect Dis (2011) 0.87
How could preventive therapy affect the prevalence of drug resistance? Causes and consequences. Philos Trans R Soc Lond B Biol Sci (2015) 0.86
Tuberculous meningitis in patients infected with human immunodeficiency virus. J Neurol (2010) 0.86
The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis. PLoS One (2012) 0.86
A Clinical Scoring Algorithm for Determination of the Risk of Tuberculosis in HIV-Infected Adults: A Cohort Study Performed at Ethiopian Health Centers. Open Forum Infect Dis (2014) 0.86
Initiating antiretrovirals during tuberculosis treatment: a drug safety review. Expert Opin Drug Saf (2011) 0.85
Strategy to better select HIV-infected individuals for latent TB treatment in BCG-vaccinated population. PLoS One (2013) 0.85
Latent Tuberculosis: Models, Computational Efforts and the Pathogen's Regulatory Mechanisms during Dormancy. Front Bioeng Biotechnol (2013) 0.85
A clinical decision support system for integrating tuberculosis and HIV care in Kenya: a human-centered design approach. PLoS One (2014) 0.84
Translating evidence into policy in low-income countries: lessons from co-trimoxazole preventive therapy. Bull World Health Organ (2011) 0.84
Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment. Clin Chest Med (2013) 0.84
Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study. Clin Infect Dis (2014) 0.84
Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study. BMC Infect Dis (2012) 0.84
Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden country. PLoS One (2013) 0.83
Tuberculosis screening in a novel substance abuse treatment center in Malaysia: implications for a comprehensive approach for integrated care. J Subst Abuse Treat (2013) 0.83
The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study. BMC Public Health (2015) 0.83
Incidence and risk factors for tuberculosis in people living with HIV: cohort from HIV referral health centers in Recife, Brazil. PLoS One (2013) 0.83
Barriers to and motivations for the implementation of a treatment programme for latent tuberculosis infection using isoniazid for people living with HIV, in upper northern Thailand. Glob J Health Sci (2013) 0.83
Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria. Tuberc Res Treat (2013) 0.82
Updates on the risk factors for latent tuberculosis reactivation and their managements. Emerg Microbes Infect (2016) 0.82
Tuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis. AIDS (2015) 0.82
Intensive case finding and isoniazid preventative therapy in HIV infected individuals in Africa: economic model and value of information analysis. PLoS One (2012) 0.82
Immunotherapeutic effects of recombinant adenovirus encoding granulocyte-macrophage colony-stimulating factor in experimental pulmonary tuberculosis. Clin Exp Immunol (2013) 0.82
Risk factors for developing active tuberculosis after the treatment of latent tuberculosis in adults infected with human immunodeficiency virus. Open Forum Infect Dis (2015) 0.82
Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention. Clin Infect Dis (2015) 0.81
HIV-Associated Tuberculosis. Clin Dev Immunol (2010) 0.81
Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study. BMC Infect Dis (2015) 0.80
Treatment of latent tuberculosis infection in HIV: shorter or longer? Curr HIV/AIDS Rep (2012) 0.80
Prevalent tuberculosis at HIV diagnosis in Rio de Janeiro, Brazil: the TB/HIV in Rio (THRio) Cohort. J Acquir Immune Defic Syndr (2014) 0.80
Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials. PLoS One (2015) 0.79
HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study. BMC Infect Dis (2014) 0.79
Added value of QuantiFERON TB-gold in-tube for detecting latent tuberculosis infection among persons living with HIV/AIDS. Biomed Res Int (2014) 0.79
Trends in AIDS-defining opportunistic illnesses incidence over 25 years in Rio de Janeiro, Brazil. PLoS One (2014) 0.79
Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model. J Acquir Immune Defic Syndr (2014) 0.79
Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana. J Acquir Immune Defic Syndr (2015) 0.79
Management of latent tuberculous infection in Norway in 2009: a descriptive cross-sectional study. Public Health Action (2013) 0.79
"It's about my life": facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa. AIDS Care (2017) 0.79
Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania. BMC Infect Dis (2015) 0.78
Tuberculosis and HIV coinfection in Europe: looking at one reality from two angles. AIDS (2016) 0.78
Interpreting tuberculin skin tests in a population with a high prevalence of HIV, tuberculosis, and nonspecific tuberculin sensitivity. Am J Epidemiol (2010) 0.78
The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection. Thorax (2016) 0.78
Potential impact of the US President's Emergency Plan for AIDS relief on the tuberculosis/HIV coepidemic in selected Sub-Saharan African countries. J Infect Dis (2013) 0.78
An evaluation of factors associated with taking and responding positive to the tuberculin skin test in individuals with HIV/AIDS. BMC Public Health (2011) 0.78
Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. JAMA (2004) 7.43
What is missing from descriptions of treatment in trials and reviews? BMJ (2008) 7.33
Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med (2007) 5.63
Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev (2009) 4.86
Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol (2011) 4.74
Number of published systematic reviews and global burden of disease: database analysis. BMJ (2003) 4.53
Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research. BMJ (2002) 3.78
Personalised care planning for adults with chronic or long-term health conditions. Cochrane Database Syst Rev (2015) 3.47
A theme issue "by, for, and about" Africa. BMJ (2005) 3.32
Taking healthcare interventions from trial to practice. BMJ (2010) 3.27
Interventions for increasing the proportion of health professionals practising in rural and other underserved areas. Cochrane Database Syst Rev (2009) 3.20
Interactive telemedicine: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2015) 3.10
Errors in the completion of the death notification form. S Afr Med J (2007) 2.94
Beta-blockers for hypertension. Cochrane Database Syst Rev (2012) 2.67
An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes. Cochrane Database Syst Rev (2011) 2.59
Putting evidence into practice: how middle and low income countries "get it together". BMJ (2004) 2.47
Should active recruitment of health workers from sub-Saharan Africa be viewed as a crime? Lancet (2008) 2.31
Conducting a meta-ethnography of qualitative literature: lessons learnt. BMC Med Res Methodol (2008) 2.28
Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis (2013) 2.16
Addressing inequalities in research capacity in Africa. BMJ (2005) 2.16
A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Public Health (2007) 2.11
Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev (2008) 1.89
Non-communicable diseases in sub-Saharan Africa: the case for cohort studies. PLoS Med (2010) 1.88
Compliance of clinical trial registries with the World Health Organization minimum data set: a survey. Trials (2009) 1.80
Families help cure tuberculosis. Lancet (2006) 1.72
Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution. BMJ (2005) 1.68
Identifying, documenting, and examining heterogeneity in systematic reviews of complex interventions. J Clin Epidemiol (2013) 1.68
Interventions to improve the use of systematic reviews in decision-making by health system managers, policy makers and clinicians. Cochrane Database Syst Rev (2012) 1.66
Why men with prostate cancer want wider access to prostate specific antigen testing: qualitative study. BMJ (2002) 1.65
Beta-blockers for hypertension. Cochrane Database Syst Rev (2012) 1.56
The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa. S Afr Med J (2006) 1.53
Promoting adherence to tuberculosis treatment. Bull World Health Organ (2007) 1.51
Material incentives and enablers in the management of tuberculosis. Cochrane Database Syst Rev (2012) 1.47
Evidence-based public health: what does it offer developing countries? J Public Health (Oxf) (2005) 1.46
A research and development agenda for systematic reviews that ask complex questions about complex interventions. J Clin Epidemiol (2013) 1.44
Against internet exceptionalism. BMJ (2002) 1.30
Patient education and counselling for promoting adherence to treatment for tuberculosis. Cochrane Database Syst Rev (2012) 1.26
Learning to DISCERN online: applying an appraisal tool to health websites in a workshop setting. Health Educ Res (2004) 1.19
Strengthening research capacity. Lancet (2002) 1.18
The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown. AIDS Rev (2009) 1.13
Interventions to improve professional adherence to guidelines for prevention of device-related infections. Cochrane Database Syst Rev (2013) 1.13
Monitoring use of knowledge and evaluating outcomes. CMAJ (2010) 1.11
Nutritional interventions for reducing morbidity and mortality in people with HIV. Cochrane Database Syst Rev (2013) 1.10
Make the money work for health in sub-Saharan Africa. Lancet (2009) 1.09
Primary care professionals providing non-urgent care in hospital emergency departments. Cochrane Database Syst Rev (2012) 1.07
Hospital at home: the evidence is not compelling. Ann Intern Med (2005) 1.07
Economic support to improve tuberculosis treatment outcomes in South Africa: a pragmatic cluster-randomized controlled trial. Trials (2013) 1.06
Reviews of qualitative evidence: a new milestone for Cochrane. Cochrane Database Syst Rev (2013) 1.05
The "Child Health Evidence Week" and GRADE grid may aid transparency in the deliberative process of guideline development. J Clin Epidemiol (2012) 1.05
Near patient testing for influenza in children in primary care: comparison with laboratory test. BMJ (2003) 1.01
Linking research and development to strengthen health systems in Africa. Trop Med Int Health (2010) 1.00
Deaths caused by HIV disease under-reported in South Africa. AIDS (2009) 0.99
Differences between tuberculosis cases infected with Mycobacterium africanum, West African type 2, relative to Euro-American Mycobacterium tuberculosis: an update. FEMS Immunol Med Microbiol (2009) 0.99
Incentives and enablers to improve adherence in tuberculosis. Cochrane Database Syst Rev (2015) 0.97
Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev (2013) 0.96
Continuity of care -- a chameleon concept. J Health Serv Res Policy (2002) 0.94
Directly observed treatment for tuberculosis. BMJ (2003) 0.94
Validation study of cause of death statistics in Cape Town, South Africa, found poor agreement. J Clin Epidemiol (2011) 0.91
Comparison of the prevalence of common bacterial pathogens in the oropharynx and nasopharynx of gambian infants. PLoS One (2013) 0.91
Comparison of alternative evidence summary and presentation formats in clinical guideline development: a mixed-method study. PLoS One (2013) 0.88
Can we rely on the best trial? A comparison of individual trials and systematic reviews. BMC Med Res Methodol (2010) 0.87
Interventions encouraging the use of systematic reviews in clinical decision-making: a systematic review. J Gen Intern Med (2010) 0.86
Cochrane and capacity building in low- and middle-income countries: where are we at? Cochrane Database Syst Rev (2013) 0.86
Pycnogenol® (extract of French maritime pine bark) for the treatment of chronic disorders. Cochrane Database Syst Rev (2012) 0.86
Ready-to-use therapeutic food for home-based treatment of severe acute malnutrition in children from six months to five years of age. Cochrane Database Syst Rev (2013) 0.84
Tools developed and disseminated by guideline producers to promote the uptake of their guidelines. Cochrane Database Syst Rev (2016) 0.84
Evidence-based African first aid guidelines and training materials. PLoS Med (2011) 0.84
Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 0.83
Beta-blockers and the treatment of hypertension: it is time to move on. Cardiovasc J Afr (2007) 0.81
Discharge planning from hospital. Cochrane Database Syst Rev (2016) 0.81
Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents. Cochrane Database Syst Rev (2014) 0.81
Economic support to improve tuberculosis treatment outcomes in South Africa: a qualitative process evaluation of a cluster randomized controlled trial. Trials (2014) 0.80
Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions. Cochrane Database Syst Rev (2011) 0.79
African HIV/AIDS trials are more likely to report adequate allocation concealment and random generation than North American trials. PLoS One (2008) 0.79
Challenges in guideline methodology. J Clin Epidemiol (2011) 0.79
What do we know about hospital at home? Lessons from international experience. Appl Health Econ Health Policy (2002) 0.78
Investigating the association between diabetes mellitus, depression and psychological distress in a cohort of South African teachers. S Afr Med J (2015) 0.78
Implications of Cochrane Review on restricting or banning alcohol advertising in South Africa. S Afr Med J (2015) 0.76
The management of an endodontically abscessed tooth: patient health state utility, decision-tree and economic analysis. BMC Oral Health (2007) 0.75
The use of patients' stories by self-help groups: a survey of voluntary organizations in the UK on the register of the College of Health. Health Expect (2000) 0.75
Chickenpox. Clin Evid (2002) 0.75
Chickenpox. Clin Evid (2002) 0.75
GRADE: complex decisions. J Clin Epidemiol (2011) 0.75
Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev (2017) 0.75
Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev (2017) 0.75
WITHDRAWN: Services for helping acute stroke patients avoid hospital admission. Cochrane Database Syst Rev (2012) 0.75
Early discharge hospital at home. Cochrane Database Syst Rev (2017) 0.75
Doctors' and patients' use of the Internet for healthcare: a study from one general practice. Health Info Libr J (2002) 0.75
Pycnogenol(®) for the treatment of chronic disorders. Cochrane Database Syst Rev (2012) 0.75
Attitude and confidence of undergraduate medical programme educators to practice and teach evidence-based healthcare: a cross-sectional survey. Int J Evid Based Healthc (2016) 0.75
Interventions for improving childhood vaccination coverage in low- and middle-income countries. S Afr Med J (2015) 0.75